Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Golimumab, a new anti-TNF monoclonal antibody, administered subcutaneously every 4 weeks, shows sustained efficacy in reducing signs and symptoms of active psoriatic arthritis…
NEW YORK (Reuters Health) – Patients with ST-elevation MI undergoing fibrinolysis followed by immediate or late invasive procedures do just as well with unfractionated heparin (UHF) or with…
NEW YORK (Reuters Health) – Intraoperative hypothermia to less than 35 C more than doubles the risk of surgical site infections after trauma laparotomy, according to a report…
NEW YORK (Reuters Health) – The 20-year survival rate for people diagnosed with thin or T1 melanomas 1 mm thick or less, the most common type, is 96%,…
NEW YORK (Reuters Health) – Results of a randomized study provide no evidence of benefit from high-concentration oxygen therapy relative to titrated oxygen therapy in patients with initially…
NEW YORK (Reuters Health) – In a small randomized study of patients with infected necrotizing pancreatitis, minimally invasive endoscopic transgastric necrosectomy was associated with a lower risk of…
NEW YORK (Reuters Health) – The need for late target lesion revascularization (TLR) with sirolimus-eluting coronary stents is reduced when patients receive ongoing statin therapy after stent implantation,…
NEW YORK (Reuters Health) – When patients with advanced gastric cancer have not benefitted from one or two chemotherapy regimens for metastatic disease, salvage chemotherapy improves their overall…
NEW YORK (Reuters Health) – Results of a study conducted in Singapore indicate that vasopressin administered to patients in prolonged cardiac arrest does not improve survival to hospital…
NEW YORK (Reuters Health) – By accelerating recovery of gastrointestinal function, use of the opioid receptor antagonist alvimopan is associated with reduced mortality and morbidity following bowel resection,…
